An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands (Q80794443)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 May 2007
edit
Language Label Description Also known as
English
An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands
scientific article published on 01 May 2007

    Statements

    title
    An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17697915
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17697915%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 January 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80794443&oldid=1767042596"